May 17, 2017
PhRMA Japan-Chief Patrik Jonsson (left), EFPIA Japan Chairman Ole Moelskov Bech The Pharmaceutical Research and Manufacturers of America (PhRMA) on May 17 reiterated its call for continuing the so-called price maintenance premium for on-patent drugs and newly pitched alternative US...read more